Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Eisuke Mekada0
Shingo Miyamoto0
Date of Patent
April 20, 2010
Patent Application Number
11917706
Date Filed
June 20, 2006
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides a cancer therapeutic agent containing as an active ingredient a substance, particularly CRM197 which inhibits the binding of HB-EGF to EGF receptor by binding to HB-EGF, wherein a cancer is selected from the group consisting of a bladder cancer, a colon cancer or peritoneal metastatic cancers of a stomach cancer and a pancreatic cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
